Skip to main content
Fig. 3 | Journal of Neuroinflammation

Fig. 3

From: Evaluation of neuroprotective and immunomodulatory properties of mesenchymal stem cells in an ex vivo retinal explant model

Fig. 3

A Representative images of wholemount retinal explants (n = 4/day) in culture at DEV 0 and DEV 5, immunolabeled with Brn3a (red) and RBPMS (green) at ×200 magnification (scale bar = 100 µm) treated daily with NMDA (50 µM). B Quantification of Brn3a+ or RBPMS+ RGCs in control group (grey bar) and Brn3a+ or RBPMS+ RGCs in NMDA-treated group (black bar) at DEV 5 from wholemount retinal explants was expressed as percentage of DEV 0 (defined as 100%). Error bars are standard error of the mean. Error bars are standard error of the mean. **P < 0.01, ****P < 0.0001

Back to article page

Journal of Neuroinflammation

ISSN: 1742-2094